Results 251 to 260 of about 112,750 (306)
Some of the next articles are maybe not open access.
DOPA Metabolism in Neuroblastoma
Medical and Pediatric Oncology, 1980AbstractBlood plasma samples from 60 neuroblastoma patients prior to, during, and following treatment were studied for their content of circulating DOPA using a radioenzymatic assay. Normal values were established from children who were tumor‐free or had other nonneurogenic tumors. The highest plasma DOPA concentration in tumor‐free or nonneuroblastoma
L, Helson, G A, Johnson, R, Smith
openaire +2 more sources
Andrologia, 2009
A clinical investigation of L-Dopa on idiopathic oligozoospermia is carried out. Thirty nine male oligozoospermic patients with primary sterility were divided in two groups. The first group of 25 patients was treated with 500 mg a day during two months. The second group of 14 patients received 750 mg a day for the same time.
J C, Lavieri, A A, Pierini
openaire +2 more sources
A clinical investigation of L-Dopa on idiopathic oligozoospermia is carried out. Thirty nine male oligozoospermic patients with primary sterility were divided in two groups. The first group of 25 patients was treated with 500 mg a day during two months. The second group of 14 patients received 750 mg a day for the same time.
J C, Lavieri, A A, Pierini
openaire +2 more sources
Psychiatry and Clinical Neurosciences, 1985
Abstract: Three cases with the occurrence of asterixis during the administration of L‐dopa were reported. Liver and metabolic functions were normal in all the patients. Upon the appearance of asterixis no other involuntary movements probably resulting from an excess administration of L‐dopa were observed.
I, Kobayashi +3 more
openaire +2 more sources
Abstract: Three cases with the occurrence of asterixis during the administration of L‐dopa were reported. Liver and metabolic functions were normal in all the patients. Upon the appearance of asterixis no other involuntary movements probably resulting from an excess administration of L‐dopa were observed.
I, Kobayashi +3 more
openaire +2 more sources
Characterization of dopa decarboxylase
Life Sciences, 1973Publisher Summary This chapter discusses characteristics of DOPA decarboxylase. DOPA decarboxylase, which catalyses the conversion of L-dopa to dopamine, was the first of the catecholamine biosynthetic enzymes to be discovered. In a study, the dopa decarboxylase of hog kidney was purified to homogeneity.
WALLACE DAIRMAN +2 more
openaire +1 more source
2019
Considering intrinsic limits of 18F-FDG PET/CT in brain and neuroendocrine tumors imaging, several radiopharmaceuticals have been developed to investigate these diseases. Among others, a promising tracer is 18F-DOPA, due to its very low rate of physiological distribution in normal brain structures of white and gray matter and the affinity for somatic ...
Ferdinando Calabria, Orazio Schillaci
openaire +1 more source
Considering intrinsic limits of 18F-FDG PET/CT in brain and neuroendocrine tumors imaging, several radiopharmaceuticals have been developed to investigate these diseases. Among others, a promising tracer is 18F-DOPA, due to its very low rate of physiological distribution in normal brain structures of white and gray matter and the affinity for somatic ...
Ferdinando Calabria, Orazio Schillaci
openaire +1 more source
Dopa-responsive dystonic camptocormia
Neurology, 2006Various central and peripheral nervous system disorders may produce camptocormia (from the Greek: “bent spine”), truncal flexion while standing and walking, which abates in sitting or recumbent positions.1 In a recent review of patients with camptocormia evaluated and treated over the last 25 years, levodopa did not improve the truncal flexion ...
openaire +2 more sources